期刊文献+

依那普利联合氢氯噻嗪治疗老年单纯性收缩期高血压的临床研究 被引量:7

Clinical study of enalapril combined with hydrochlorothiazide in treatment of elder patients with simple systolic hypertension
暂未订购
导出
摘要 目的评价依那普利联合氢氯噻嗪治疗老年单纯性收缩期高血压的降压疗效和安全性。方法 54例老年单纯性收缩期高血压患者随机服用依那普利5~10mg或依那普利5~10mg联合氢氯噻嗪25~50mg共8周,服药前后行24h动态血压监测。结果依那普利联合氢氯噻嗪联合治疗组和依那普利单药治疗组均能有效降低血压。联合治疗组总有效率为93.1%,单药治疗组总有效率为88.0%,联合治疗组降压效果优于单药治疗组,差异有统计学意义(P<0.05)。联合治疗组比单药治疗组降低收缩压的效果更显著,差异有统计学意义(P<0.05)。两组治疗前、后血糖、肾功能、电解质均无明显变化。两组药物不良反应发生率低,症状轻微,均不需要停药治疗。结论依那普利联合氢氯噻嗪治疗老年单纯性收缩期高血压优于依那普利单药治疗组,疗效确切,不良反应少,耐受性好,值得临床推广。 Objective To evaluate the depressurization effect and safety of enalapril combined with hydrochlorothiazide in the treatment of elder patients with simple systolic hypertension. Methods Fifty-four elder patients with simple systolic hypertension randomly received 5 to 10 mg of enalapril or 5 to 10 mg of enalapril combined with 25-50 mg of hydrochlorothiazide for 8 weeks. Before and after medication, 24-hour dynamic blood pressure monitoring was conducted. Results Both the enalapril combined with hydrochlorothiazide treatment and the single enalapril treatment could effectively reduce blood pressure. The combination treatment group had a total effective rate of 93.1% and the single treatment group had a total effective rate of 88.0%. The depressurization effect of the combination treatment group was superior to that of the single treatment group, with statistically significant difference (P 0.05). None of the blood sugar, renal function and electrolyte changed significantly in both groups after the treatment. Both groups had low incidence rates of adverse drug reactions and mild symptoms, not requiring drug withdrawal. Conclusion In the treatment of elder patients with simple systolic hypertension, enalapril combined with hydrochlorothiazide is superior to single analapril, shows accurate curative effects, few adverse reactions and good tolerance, thereby worthy of clinical promotion.
出处 《中国当代医药》 2013年第1期85-86,88,共3页 China Modern Medicine
关键词 高血压 老年人 依那普利 临床研究 Hypertension Elder Enalapril Clinical study
  • 相关文献

参考文献12

二级参考文献45

  • 1张小松,张新利.高血压诊断和治疗的新观点[J].中国基层医药,2004,11(8):1011-1012. 被引量:4
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2611
  • 3姚苏宁,严小惠.高血压病社区药物治疗最佳方案与经济学评价[J].中国全科医学,2005,8(10):817-818. 被引量:33
  • 4汪德娴,赵玮,孙燕淑,陈岩,田清平.动态血压节律与靶器官损害的临床研究[J].北京医学,2006,28(3):135-138. 被引量:27
  • 5[2]Douglas SA,Ohlstein EH.Human urotensin-Ⅱ,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease[J].Trends Cardiovasc Med,2000,10:229-237.
  • 6[3]Charles CJ,Rademaker MT,Richards AM,et al.Urotensin Ⅱ:evidence for cardiac,hepatic and renal production[J].Peptides,2005,26:2211-2214.
  • 7[4]Douglas SA,Ohlstein EH.Urotensin receptors,in Girdalstone D (ed):The IUPHAR compendium of receptor characterization and classification[M].London,IUPHAR Media,2000:365-372.
  • 8[5]Cheung BM,Leung R,Man YB,et al.Plasma concentration of urotensinⅡis raised in hypertension[J].J Hypertens,2004,22:1341-1344.
  • 9[6]Behm DJ,Doe CP,Douglas SA,et al.Urotensin Ⅱ:a novel systemic hypertensive factor in the cat[J].Naunyn Schmiedebergs Arch Pharmacol,2004,369:274-280.
  • 10[7]Lin Y,Tsuchihashi T,Matsumura K,et al.Central cardiovascular action of urotensin Ⅱ in spontaneously hypertensive rats[J].Hypertens Res,2003,26:839-845.

共引文献214

同被引文献53

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部